Evidence map›Paper›PMID 37957530›Full record

ReviewCancer causes & control : CCC2023

Re-visiting the call for translation of cancer survivorship research: collaborative multidisciplinary approaches to improve translation and dissemination.

Betsy Risendal, Cynthia A Thomson, Aaron Seaman, Rachel Hirschey, Linda Overholser

Abstract readReview
In one paragraph

Review in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Betsy RisendalColorado School of Public Health, Community and Behavioral Health, University of Colorado Denver, 13001 E. 17Th Place, Bldg 500, MS F538, Aurora, CO, 80045, USA. betsy.risendal@cuanschutz.edu.ORCID http://orcid.org/0000-0002-2222-6399
Cynthia A ThomsonHealth Promotion Sciences, University of Arizona, Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.ORCID http://orcid.org/0000-0003-3645-7048
Aaron SeamanDepartment of General Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa, USA.ORCID http://orcid.org/0000-0002-1680-1334
Rachel HirscheySchool of Nursing, University of North Carolina, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-8358-0650
Linda OverholserSchool of Medicine Division of General Internal Medicine, University of Colorado Denver, Aurora, CO, USA.ORCID http://orcid.org/0000-0002-2853-5694

Funding

Rocky Mountain Prevention Research CenterU48DP006399 · DP · UNIVERSITY OF COLORADO DENVER · PI LEIFERMAN, JENN A, PUMA, JINI · 2018 to 2023
$6.9M
CDC HHS U48 DP006389CDC HHS U48 DP006399CDC HHS U48 DP006400CDC HHS U48 DP006413NCCDPHP CDC HHS U48 DP006399
6 · The paper itself

Abstract

backgroundThe number of cancer survivors in the US is dramatically increasing and survivors are living longer, making the ongoing care and quality of life in this growing population an important public health issue. Although there has been significant progress in cancer survivorship research, gaps in translating this research to real-world settings to benefit survivors remain.

methodsThe number and type of cancer survivorship research activities in past and current projects were gathered in reports and work plans from the Cancer Prevention and Control Research Network (CPCRN). Additionally, current cross-center projects were aligned with common constructs in dissemination and implementation science to provide a narrative review of progress on translational research.

resultsA review of historical activities in the CPCRN indicates that there has been consistent engagement in survivorship from multiple institutions over the last decade, generating 84 grants, 168 papers and 162 presentations. The current membership of the Survivorship Workgroup includes multiple disciplines and all 8 participating institutions. Together these Workgroup members have developed 6 projects, all of which address multiple domains in translational research such as feasibility, practicality, and organizational and cultural factors that affect implementation.

conclusionsThis review of past and ongoing activities in the CPCRN suggests that survivorship has been a consistent priority including the translation of evidence-based approaches into practice. Specific gaps in the translational research agenda that could be the focus of future investigations by Workgroup members and others include the practical and logistic aspects of interventions such as cost and policy.

Indexed as

Cancer SurvivorsNeoplasmsDelivery of Health CareHumansQuality of LifeTranslational Research, BiomedicalCancerCancer survivorshipDissemination scienceTranslational science

Identifiers

PMID37957530
PMCPMC10689512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.